-
Endo Pharmaceuticals Inc. v. Roxane Laboratories, Inc. DC CAFC
- 1:13-cv-03288
- S.D.N.Y.
- Judge: J. Paul Oetken
- Filed: 05/15/2013
- Closed: 06/29/2016
- Latest Docket Entry: 06/06/2022
- PACER
- Docket updated daily
1
Plaintiff
1
Defendant
1
Accused
Product
3
Patents-in-Suit
1,142
Days in
Litigation
-
Endo Pharmaceuticals Inc. v. Roxane Laboratories, Inc. DC CAFC
- 1:13-cv-03288
- S.D.N.Y.
- Judge: J. Paul Oetken
- Filed: 05/15/2013
- Closed: 06/29/2016
- Latest Docket Entry: 06/06/2022
- PACER
- Docket updated daily
Market Sector
Biotech and Pharma
Assigned Judge
Outcome Summary
- Patent Information
-
Infringement
Roxane Laboratories Incorporated
- 2 Details
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Generic oxymorphone hydrochloride extended release tabletsgeneric version of OPANA ER | US 8,309,122 B2 | All Asserted Claims |
Infringement
Entry 235Entry 195 |
| Generic oxymorphone hydrochloride extended release tabletsgeneric version of OPANA ER | US 8,329,216 B2 |
40, 42
|
Infringement
Entry 235Entry 195 |
-
Damages
